Trinity Legacy Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Buy
6,340
+172
+3% +$13.9K 0.11% 79
2026
Q1
$544K Sell
6,168
-56,169
-90% -$5.38M 0.12% 82
2025
Q4
$5.99M Buy
62,337
+691
+1% +$67.1K 1.37% 26
2025
Q3
$5.59M Buy
61,646
+1,487
+2% +$137K 1.29% 32
2025
Q2
$5.4M Buy
60,159
+708
+1% +$60K 1.31% 28
2025
Q1
$5.06M Buy
59,451
+16,713
+39% +$1.5M 1.28% 32
2024
Q4
$3.41M Sell
42,738
-13,154
-24% -$1.14M 0.88% 51
2024
Q3
$5.03M Buy
55,892
+4,181
+8% +$352K 1.29% 33
2024
Q2
$4.07M Buy
51,711
+3,647
+8% +$299K 1.16% 37
2024
Q1
$4.19M Buy
+48,064
New +$4.1M 1.23% 33
2023
Q2
Sell
-2,611
Closed -$210K 90
2023
Q1
$210K Buy
+2,611
New +$213K 0.08% 82

Other funds holding MDT

Trinity Legacy Partners's MDT Position: Q2 2026 in Review

Trinity Legacy Partners increased its Medtronic (MDT) stake by 2.8% in Q2 2026, buying an estimated $13.9K and bringing the position to 6,340 shares worth $530K. The position accounts for 0.11% of the portfolio, ranked #79.

Trinity Legacy Partners first reported a position in MDT in Q1 2023 and has held it in 11 quarters since. The position peaked at $5.99M in Q4 2025. 2,133 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Trinity Legacy Partners held 6,340 shares of Medtronic worth $530K as of Q2 2026.
  • Trinity Legacy Partners bought 172 Medtronic shares in Q2 2026, an estimated $13.9K.
  • Medtronic made up 0.11% of Trinity Legacy Partners's portfolio in Q2 2026, its #79 holding.
  • Trinity Legacy Partners first reported a position in Medtronic in Q1 2023 and has held it in 11 quarters since.
  • Trinity Legacy Partners's Medtronic position peaked at $5.99M in Q4 2025.
  • 2,133 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Trinity Legacy Partners's 13F filing for Q2 2026, filed 24 Jul 2026.